TRIP
52
3
CNP
52
3
CVS
40
3
MNST
59
3
ADI
73
2
HPQ
37
2
CAG
34
-2
BLK
63
5
EXR
26
2
FFIV
51
4
CTAS
43
3
XOM
50
5
CA
21
-9
R
67
4
NTAP
56
-3
PFG
55
2
NKE
31
-5
SLG
37
6
INTC
40
-3
FLS
63
2
TRIP
52
3
CNP
52
3
CVS
40
3
MNST
59
3
ADI
73
2
HPQ
37
2
CAG
34
-2
BLK
63
5
EXR
26
2
FFIV
51
4
CTAS
43
3
XOM
50
5
CA
21
-9
R
67
4
NTAP
56
-3
PFG
55
2
NKE
31
-5
SLG
37
6
INTC
40
-3
FLS
63
2
Financhill
Back

Intellia Therapeutics, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
23

NTLA
Intellia Therapeutics, Inc.

Last Price:
$9.41
Seasonality Move:
-6.88%
Sell
41

MNPR
Monopar Therapeutics, Inc.

Last Price:
$70.68
Seasonality Move:
25.93%
Sell
23
Intellia Therapeutics, Inc. (NTLA) is a Sell

Is Intellia Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Intellia Therapeutics, Inc. [NTLA] share price is $9.70. The Score for NTLA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.92. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics, Inc.'s stock price today?

  • The Intellia Therapeutics, Inc. share price today is $9.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.64 Sell
Relative Strength Index (14 RSI): 47.92 Sell
Chaikin Money Flow: 1572788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.37 - 9.41) Buy
Bollinger Bands (100): (8.05 - 18.93) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.54 Sell
Relative Strength Index (14 RSI): 41.3 Sell
Chaikin Money Flow: 7856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.72 - 85.64) Sell
Bollinger Bands (100): (46.03 - 89.35) Buy

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.18 Buy
20-day SMA: 9.04 Buy
50-day SMA: 13.02 Sell
200-day SMA: 11.33 Sell
8-day EMA: 9.23 Buy
20-day EMA: 9.47 Buy
50-day EMA: 11.34 Sell
200-day EMA: 12.84 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.44 Sell
20-day SMA: 77.62 Sell
50-day SMA: 81.13 Sell
200-day SMA: 52.54 Buy
8-day EMA: 71.33 Sell
20-day EMA: 75.43 Sell
50-day EMA: 76.56 Sell
200-day EMA: 56.82 Buy

Intellia Therapeutics, Inc. Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.38 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Intellia Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):